lung-cancer Articles | Developments Today

Proton therapy leads to positive survival and quality of life outcomes for patients with lower grade glioma

Proton Therapy Shows Promising Survival and Quality-of-Life Gains for Lung Cancer

Prospective data show proton beam therapy improves survival while sparing healthy tissue and preserving quality of life in lung cancer patients.

Key Takeaways

Proton therapy achieves 64% three-year survival for stage III lung cancer versus 24-38% with conventional radiation
Median survival reached 49.1 months compared to 28.7 months for matched patients receiving standard X-ray treatment
Patients showed significantly fewer severe side effects including lower rates of radiation pneumonitis and esophagitis

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

Potential immune evasion mechanism identified in premalignant lung lesions

Health

MicroRNA Discovery Reveals How Early Lung Lesions Dodge the Immune System

Researchers identify miR-149-5p as a key driver of immune escape in bronchial lesions that can progress to squamous cell lung cancer.

Key Takeaways

Boston University identifies miR-149-5p as a microRNA that suppresses immune recognition in premalignant lung lesions
The microRNA silences NLRC5, a master regulator of antigen presentation, allowing abnormal cells to hide from immune surveillance
Analysis of 167 bronchial biopsies showed a consistent inverse relationship between miR-149-5p and NLRC5 in progressive lesions

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

Proton therapy treatment gantry at Mayo Clinic for precision cancer radiation therapy

Health

Proton Therapy Shows Strong Survival Results for Lung Cancer

New clinical data shows proton beam therapy delivers strong survival rates for advanced lung cancer while reducing damage to healthy tissue.

Key Takeaways

Multi-institutional data shows proton therapy achieves survival rates comparable to or better than conventional radiation for lung cancer
Protons deposit energy at a precise depth, sparing the heart, esophagus, and healthy lung tissue from radiation damage
As proton therapy centers multiply and costs decline, the evidence increasingly supports real clinical benefits over theoretical advantages

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

CT scan of the thorax showing a peripheral bronchial carcinoma

Health

Immune Evasion Mechanism Found in Pre-Cancer Lung Lesions

Scientists discover how premalignant lung cells suppress immune surveillance, revealing potential targets for intercepting cancer before it fully develops.

Key Takeaways

Pre-cancerous lung lesions already deploy immune evasion strategies typically seen only in advanced established tumors
Cells upregulate PD-L1 and downregulate MHC class I molecules to hide from immune surveillance before cancer forms
Understanding how some lesions progress while others regress could enable cancer interception at the earliest treatable stage

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

#lung-cancer

Proton Therapy Shows Promising Survival and Quality-of-Life Gains for Lung Cancer

MicroRNA Discovery Reveals How Early Lung Lesions Dodge the Immune System

Proton Therapy Shows Strong Survival Results for Lung Cancer

Immune Evasion Mechanism Found in Pre-Cancer Lung Lesions

Proton Therapy Shows Promising Survival and Quality-of-Life Gains for Lung Cancer

MicroRNA Discovery Reveals How Early Lung Lesions Dodge the Immune System

Proton Therapy Shows Strong Survival Results for Lung Cancer

Immune Evasion Mechanism Found in Pre-Cancer Lung Lesions